Gp-91 mediates histone deacetylase inhibition-induced cardioprotection

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1803, Issue 7, 2010, Pages 872-880

  Zhao, Ting C ^a   Zhang, Ling X ^b   Cheng, Guangmao ^c   Liu, Jun T ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Gp 91; Histone deacetylase; Ischemia; Myocardial infarction; NADPH oxidase

Indexed keywords

CASPASE 3; GLYCOPROTEIN GP 91; HISTONE DEACETYLASE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TRICHOSTATIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE DELETION; GENETIC TRANSFECTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE FUNCTION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIMULATION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; CELL SURVIVAL; HEART; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; NADPH OXIDASE; RANDOM ALLOCATION; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; RNA, SMALL INTERFERING;

MUS;

EID: 77953363510     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.04.007     Document Type: Article

References (46)

1. Cheung P., Allis C.D., Sassone-Corsi P. Signaling to chromatin through histone modifications. Cell 2000, 103:263-267.
2. Hansen J.C., Tse C., Wolffe A.P. Structure and function of the core histone N-termini: more than meets the eye. Biochemistry 1998, 37:17637-17641.
3. Luger K., Mader A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8A resolution. Nature 1997, 389:251-260.
4. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
5. Turner B.M. Histone acetylation and an epigenetic code. Bioessays 2000, 22:836-845.
6. Hassig C.A., Tong J.K., Fleischer T.C., Owa T., Grable P.G., Ayer D.E., Schreiber S.L. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc. Natl Acad. Sci. USA 1998, 95:3519-3524.
7. Verdin E., Dequiedt F., Kasler H.G. Class II histone deacetylases: versatile regulators. Trends Genet. 2003, 19:286-293.
8. Fischle W., Emiliani S., Hendzel M.J., Nagase T., Nomura N., Voelter W., Verdin E. A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1. Biol. Chem. 1999, 274:11713-11720.
9. Grozinger C.M., Hassig C.A., Schreiber S.L. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc. Natl Acad. Sci. USA 1999, 96:4868-4873.
10. Wang A.H., Bertos N.R., Vezmar M., Pelletier N., Crosato M., Heng H.H., Th'ng J., Han J., Yang X.J. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol. Cell Biol. 1999, 19:7816-7827.
11. Vigushi D.M., Coombes R.C. Targeted histone deacetylase inhibition for cancer therapy. Curr. Cancer Target 2004, 4:205-218.
12. Zhao T.C., Cheng G., Zhang L.X., Tseng Y.T., Padbury J.F. Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovasc. Res. 2007, 76:473-481.
13. Antos C.L., McKinsey T.A., Dreitz M., Hollingsworth L.M., Zhang C.L., Schreiber K., Rindt Qian Y.R.H., Gorczynski R.J., Olson E.N. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J. Biol. Chem. 2003, 278:28930-28937.
14. Kee H.J., Sohn I.S., Nam K.I., Park J.E., Yin Z., Ahn Y., Jeong M.H., Bang Y.J., Kim N., Kim J.K., Kim K.K., Epstein J.A., Kook H. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 2006, 113:51-59.
15. Kong Y., Tannous P., Lu G., Berenji K., Rothermel B.A., Olson E.N., Hill J.A. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 2006, 113:2579-2588.
16. Ren M., Leng Y., Jeong M., Leeds P.R., Chuang D.M. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J. Neurochem. 2004, 89:1358-1367.
17. Leto T.L. Inflammation Basic and Clinical Correlates 1999, 769-787. Lippincott, Wilkins, Philadelphia. J.I. Gallin, R. Snyderman (Eds.).
18. dler V., Yin Z., Tew K.D., Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 1999, 18:6104-6111.
19. Ebert B.L., Bunn H.F. Regulation of the erythropoietin gene. Blood 1999, 94:1864-1877.
20. 3 receptor induced delayed cardioprotection in mouse heart: essential role of gp91 subunit of NADPH oxidase. Circulation 2002, 106(Supplement II):II-314.
21. phox-containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 2000, 87:26-32.
22. Bayraktutan U., Blayney L., Shah A.M. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1903-1911.
23. phox Is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J. Biol. Chem. 1996, 271:23317-23321.
24. phox cDNA and functional analysis in a human X-linked chronic granulomatous disease cell line. Blood 1996, 87:2005-2010.
25. Dai Y., Rahmani M., Dent P., Grant S. Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation. Mol. Cell Biol. 2005, 25:5429-5444.
26. Zhao T., Parikh P., Bhashyam S., Bolukoglu H., Poornima I., Shen Y.T., Shannon R.P. Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts. J. Pharmacol. Exp. Ther. 2006, 317:1106-1113.
27. Zhao T.C., Kukreja R.C. Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF-kappa B, iNOS and mitochondrial K(ATP) channel. J. Mol. Cell Cardiol. 2002, 34:263-277.
28. 3 receptor-induced delayed cardioprotection in mouse. Am. J. Physiol. Heart Circ Physiol. 2003, 285:H434-H441.
29. Zhao T.C., Taher M.M., Valerie K.C., Kukreja R.C. p38 Triggers late preconditioning elicited by anisomycin in heart: involvement of NF-kappaB and iNOS. Circ. Res. 2001, 89:915-922.
30. phox. Proc. Natl Acad. Sci. USA. 1993, 90:9832-9836.
31. Engelbrecht A.M., Niesler C., Page C., Lochner A. p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes. Basic Res. Cardiol. 2004, 99:338-350.
32. Tantini B., Fiumana E., Cetrullo S., Pignatti C., Bonavita F., Shantz L.M., Giordano E., Muscari C., Flamigni F., Guarnieri C., Stefanelli C., Caldarera C.M. Involvement of polyamines in apoptosis of cardiac myoblasts in a model of simulated ischemia. J. Mol. Cell Cardiol. 2006, 40:775-782.
33. Li M., Dai X., Watts S., Kreulen D., Fink G. Increased superoxide levels in ganglia and sympathoexcitation are involved in sarafotoxin 6c-induced hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R1546-R1554.
34. Yoshida M., Kijima M., Akita M., Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 1990, 265:17174-17179.
35. Finnin M.S., Donigian J.R., Cohen A., Richon V.M., Rifkind R.A., Marks P.A., Breslow R., Pavletich N.P. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 1999, 401:188-193.
36. Granger A., Abdullah I., Huebner F., Stout A., Wang T., Huebner T., Epstein J.A., Gruber P.J. Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J. 2008, 22:3549-3560.
37. Gallo P., Latronico M.V., Gallo P., Grimaldi S., Borgia F., Todaro M., Jones P., Gallinari P., De Francesco R., Ciliberto G., Steinkühler C., Esposito G., Condorelli G. Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. Cardiovasc. Res. 2008, 80:416-424.
38. Wang H.D., Xu S., Johns D.G., Du Y., Quinn M.T., Cayatte A.J., Cohen R.A. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ. Res. 2001, 88:947-953.
39. Peart J.N., Gross G.J. Cardioprotection following adenosine kinase inhibition in rat hearts. Basic Res. Cardiol. 2005, 100:328-336.
40. Sun J.Z., Tang X.L., Park S.W., Qiu Y., Turrens J.F., Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J. Clin. Invest. 1996, 97:562-576.
41. Oldenburg O., Cohen M.V., Yellon D.M., Downey J.M. Mitochondrial K(ATP) channels: role in cardioprotection. Cardiovasc. Res. 2002, 55:429-437.
42. Heinzel F.R., Luo Y., Li X., Boengler K., Buechert A., García-Dorado D., Di Lisa F., Schulz R., Heusch G. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ. Res. 2005, 97:583-586.
43. 2+ overload. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H1900-H1908.
44. Geiszt M., Kopp J.B., Varnal P., Leto T.L. Identification of Renox, and NAD(P)H oxidase in kidney. Proc. Natl Acad. Sci. USA 2000, 97:8010-8014.
45. Vitadello M., Penzo D., Petronilli V., Michieli G., Gomirato S., Menabò R., Di Lisa F., Gorza L. Overexpression of the stress protein Grp94 reduces cardiomyocyte necrosis due to calcium overload and simulated ischemia. FASEB J. 2003, 17:923-925.
46. Bendall J.K., Cave A.C., Heymes C., Gall N., Shah A.M. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 2002, 105:293-296.